Showing results (401-410 of 499) with videos related to
Sort By:
Pageof 50
Hormone Research|August 14, 1998
Serum insulin-like growth factor-I, IGF binding protein-3 and IGFBP-3 protease activity after cranial irradiationV Tillmann, S M Shalet, D A Price, et al.British Journal of Anaesthesia|March 11, 2014
Effect of supervised aerobic exercise rehabilitation on physical fitness and quality-of-life in survivors of critical illness: an exploratory minimized controlled trial (PIX study)A M Batterham, S Bonner, J Wright, et al.Clinical Endocrinology|January 17, 2004
Successful treatment of childhood-onset Cushing's disease is associated with persistent reduction in growth hormone secretionP V Carroll, J P Monson, A B Grossman, et al.The Journal of Clinical Endocrinology and Metabolism|November 10, 2001
Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiencyE Hernberg-Ståhl, A Luger, R Abs, et al.Clinical Endocrinology|May 14, 1998
The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activityS V Gelding, N F Taylor, P J Wood, et al.Journal of the Royal Society of Medicine|May 1, 1986
Relationship between retinopathy and glycaemic control in insulin-dependent and non-insulin-dependent diabetesJ P Monson, G Koios, G C Toms, et al.The British Journal of Radiology|October 25, 2001
MRI of pancreatic neuroendocrine tumoursN J Owen, S A Sohaib, P D Peppercorn, et al.British Journal of Anaesthesia|October 28, 1999
Risk factors for cardiovascular death within 30 days after anaesthesia and urgent or emergency surgery: a nested case-control studyS J Howell, J W Sear, Y M Sear, et al.British Journal of Anaesthesia|March 20, 1998
Risk factors for cardiovascular death after elective surgery under general anaesthesiaS J Howell, Y M Sear, D Yeates, et al.Familial Cancer|November 1, 2016
Risk algorithms that include pathology adjustment for HER2 amplification need to make further downward adjustments in likelihood scoresD G Evans, E R Woodward, S J Howell, et al.Pageof 50